Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2016)

Arrowhead Pharmaceuticals' Other Operating Expenses history spans 7 years, with the latest figure at $7.9 million for Q4 2016.

  • For Q4 2016, Other Operating Expenses rose 11.16% year-over-year to $7.9 million; the TTM value through Sep 2017 reached $7.9 million, up 306.9%, while the annual FY2016 figure was -$3.8 million, 109.26% down from the prior year.
  • Other Operating Expenses reached $7.9 million in Q4 2016 per ARWR's latest filing, up from -$26.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $47.4 million in Q3 2012 to a low of -$26.1 million in Q3 2016.
  • Average Other Operating Expenses over 5 years is $6.2 million, with a median of $4.8 million recorded in 2014.
  • Peak YoY movement for Other Operating Expenses: surged 248.22% in 2015, then plummeted 307.38% in 2016.
  • A 5-year view of Other Operating Expenses shows it stood at $2.5 million in 2012, then rose by 21.48% to $3.0 million in 2013, then skyrocketed by 81.47% to $5.5 million in 2014, then surged by 30.04% to $7.1 million in 2015, then increased by 11.16% to $7.9 million in 2016.
  • Per Business Quant, the three most recent readings for ARWR's Other Operating Expenses are $7.9 million (Q4 2016), -$26.1 million (Q3 2016), and $7.7 million (Q2 2016).